PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Series of new security seals for screw caps provide product protection for industry and cosmetics

Double protection for screw caps "DiamondVOID" labels protect against packaging tampering Securikett is expanding its portfolio of security labels for tamper-p...
Continue Reading →
News

CymaBay begins phase 3 liver disease study

IDEAL study aims to determine the impact of seladelpar on alkaline phosphatase levels. CymaBay Therapeutics – a company focusing on providing access to therapies ...
Continue Reading →
News

CNX acquires four cancer drugs from Clinigen

The purchased therapies concerned are Cardioxane, Totect, Ethyol and Savene. CNX Therapeutics – a company focusing on boosting medicine access – has announced tha...
Continue Reading →
News

Novartis’ remibrutinib shows promise for patients with CSU

Highly selective inhibitor therapy treats patients with chronic spontaneous urticaria. Novartis has shared positive top-line results from two late-stage studies a...
Continue Reading →
News

Green light for one of Europe’s largest life sciences campus

UBS Asset Management and Reef Group secure approval for the Stevenage-based facility. Reef Group and UBS Asset Management have gained approval to develop one of E...
Continue Reading →
News

AlzeCure delivers positive NeuroRestore candidate results

The therapy reaches and activates areas of the brain that are central to cognitive enhancement. AlzeCure Pharma, a company that develops small molecule candidate ...
Continue Reading →
News

CPHI MILAN RETURNS TO FIERA MILANO AND THE LOMBARDY PHARMA REGION FOR 2024

The exhibition centre hosts the international event – renowned as 'the heart of pharma' – in Europe's premier pharma manufacturing region CPHI, the world's la...
Continue Reading →
News

Infex candidate nominated for COV-X programme

Therapy targets the coronavirus PLPRO enzyme essential for the evasion of host immune response. Infex Therapeutics, a company focusing on anti-infectives, has rev...
Continue Reading →
News

Taiho begins latest non-small cell lung cancer trial

A combination of zipalertinib and chemotherapy will be evaluated as a treatment for adults. Taiho Oncology has announced the launch of its phase 3 REZILIENT3 stud...
Continue Reading →
News

Evox Therapeutics reaches gene therapy agreement

Partnership with Icahn School of Medicine will involve developing exoAAV vectors for heart disease patients. Evox Therapeutics, an exosome therapeutics company, h...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026